SHIRLEY RYAN ABILITYLAB — History
CCN 143026 | 3-year financial timeline | COVID resilience: 60/100
🛡️ Public data only — no PHI permitted on this instance.
$305M
Latest Revenue (FY2022)
+7.4%
Revenue CAGR (3yr)
-30.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $264M | $282M | $305M | +7.9% | +7.4% |
| Operating Expenses | $345M | $369M | $398M | +7.6% | +7.3% |
| Operating Margin | -30.6% | -30.8% | -30.4% | +1.2% | +0.0% |
| Net Income | $-81M | $-87M | $-93M | -6.6% | +0.0% |
| Licensed Beds | 226 | 225 | 225 | +0.0% | -0.2% |
| Total Patient Days | 78,878 | 77,921 | 77,695 | -0.3% | -0.8% |
| Medicare Day % | 30% | 28% | 27% | -3.2% | -5.5% |
| Medicaid Day % | 3% | 3% | 3% | +1.3% | -5.6% |
COVID Impact & Recovery
Resilience Score: 60/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.3% ($264M → $305M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.4%
This Hospital
+7.6%
State Avg
Latest Margin
-30.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $325M | -30.4% |
| FY2024 (proj) | $345M | -30.3% |
| FY2025 (proj) | $365M | -30.2% |